GNFT - צמיחת הכנסות ב-12 חודשים נגררים genfit.com

סמל מסחרי של Genfit SA (GNFT)

Genfit S.A. (GNFT) revenues are volatile due to the clinical status of its pipeline and infrequent partner payments. Year-over-year sales volume dynamics for the TTM confirm a dependency on the NIS4 diagnostic ecosystem, where the parameter value is -44.40. The company is currently striving for leadership in primary biliary cholangitis therapy, leveraging the potential of Iqirvo within the rare liver disease segment.

Genfit SA (GNFT) - צמיחת מכירות משנה לשנה (TTM) מ-11.02.2024 עד 06.12.2025

GENFIT - פילוחים אנליטיים ומדדי מפתח (GNFT)

- מחיר ותחזית קונצנזוס למחירים:
הערכת שווי פונדמנטלית של החברה:GENFIT
מוצר ממותג של genfit.com

Conservative capital demands transparency regarding expansion rates, which is why analyzing rolling-year revenue dynamics allows investors to filter out short-term noise and determine the true resilience of the business. This year-over-year sales growth percentage (over 4 quarters) measures the scaling speed of Genfit S.A. amid the fierce biopharmaceutical patent race, confirming the effectiveness of inhibitor molecule protection through commercialization rates.